Figure 1b

Evaluation of long antigen exposition dendritic cell therapy (LANEX-DC®) in the adjuvant treatment of pancreatic cancer – results of a single center analysis

Frank Gansauge* and Bertram Poch

Published: 25 July, 2022 | Volume 6 - Issue 1 | Pages: 006-008

acst-aid1027-g001b

Figure 1b:

Overall survival (5 years) in the adjuvant treatment of pancreatic cancer patients (n = 28) was 17,9% and the median survival time was 29,4 months.

Read Full Article HTML DOI: 10.29328/journal.acst.1001027 Cite this Article Read Full Article PDF

More Images

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?